Efficacy, Safety, and Survival Factors for Sorafenib Treatment in Japanese Patients with Advanced Hepatocellular CarcinomaMasahito Nakano, Kunitaka Fukuizumi, Nobuyoshi Tajiri et al.|Oncology|2012Cited by 34
Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular CarcinomaHideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu et al.|Cancers|2021Cited by 32
Metabolic management after sustained virologic response in elderly patients with hepatitis C virus: A multicenter studyTomoya Sano, Keisuke Amano, Tatsuya Ide et al.|Hepatology Research|2023Cited by 23
Hepatic Arterial Infusion Chemotherapy with Cisplatin versus Sorafenib for Intrahepatic Advanced Hepatocellular Carcinoma: A Propensity Score-Matched AnalysisYuki Zaizen, Takuji Torimura, Masahito Nakano et al.|Cancers|2021Cited by 16